nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—prostate cancer—Hydrocortisone—rheumatoid arthritis	0.225	0.388	CpDpCtD
Metoclopramide—CYP11B2—Hydrocortisone—rheumatoid arthritis	0.154	0.469	CbGbCtD
Metoclopramide—prostate cancer—Betamethasone—rheumatoid arthritis	0.137	0.237	CpDpCtD
Metoclopramide—prostate cancer—Dexamethasone—rheumatoid arthritis	0.137	0.237	CpDpCtD
Metoclopramide—CYP11B1—Hydrocortisone—rheumatoid arthritis	0.1	0.305	CbGbCtD
Metoclopramide—migraine—Prednisone—rheumatoid arthritis	0.0799	0.138	CpDpCtD
Metoclopramide—CYP17A1—Dexamethasone—rheumatoid arthritis	0.0623	0.189	CbGbCtD
Metoclopramide—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00734	0.0223	CbGbCtD
Metoclopramide—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00483	0.0147	CbGbCtD
Metoclopramide—Sunitinib—IRAK1—rheumatoid arthritis	0.00106	0.404	CrCbGaD
Metoclopramide—Sunitinib—TYK2—rheumatoid arthritis	0.000608	0.232	CrCbGaD
Metoclopramide—Sunitinib—BLK—rheumatoid arthritis	0.000571	0.218	CrCbGaD
Metoclopramide—Procainamide—SLC22A4—rheumatoid arthritis	0.000383	0.146	CrCbGaD
Metoclopramide—Cardiac arrest—Triamcinolone—rheumatoid arthritis	0.000171	0.00319	CcSEcCtD
Metoclopramide—Cardiac arrest—Methylprednisolone—rheumatoid arthritis	0.000171	0.00318	CcSEcCtD
Metoclopramide—Respiratory failure—Methotrexate—rheumatoid arthritis	0.000167	0.0031	CcSEcCtD
Metoclopramide—Nausea—Penicillamine—rheumatoid arthritis	0.000166	0.00308	CcSEcCtD
Metoclopramide—Depression—Cyclosporine—rheumatoid arthritis	0.000165	0.00308	CcSEcCtD
Metoclopramide—Jaundice—Cyclosporine—rheumatoid arthritis	0.000162	0.00301	CcSEcCtD
Metoclopramide—Muscle spasms—Leflunomide—rheumatoid arthritis	0.000161	0.003	CcSEcCtD
Metoclopramide—Leukopenia—Azathioprine—rheumatoid arthritis	0.000159	0.00296	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—rheumatoid arthritis	0.000157	0.00292	CcSEcCtD
Metoclopramide—Asthma—Triamcinolone—rheumatoid arthritis	0.000156	0.0029	CcSEcCtD
Metoclopramide—Cardiac arrest—Betamethasone—rheumatoid arthritis	0.000155	0.00289	CcSEcCtD
Metoclopramide—Cardiac arrest—Dexamethasone—rheumatoid arthritis	0.000155	0.00289	CcSEcCtD
Metoclopramide—Angioedema—Leflunomide—rheumatoid arthritis	0.000153	0.00285	CcSEcCtD
Metoclopramide—Bronchospasm—Methylprednisolone—rheumatoid arthritis	0.000153	0.00284	CcSEcCtD
Metoclopramide—Leukopenia—Leflunomide—rheumatoid arthritis	0.00015	0.0028	CcSEcCtD
Metoclopramide—Palpitations—Leflunomide—rheumatoid arthritis	0.000148	0.00276	CcSEcCtD
Metoclopramide—Gynaecomastia—Methotrexate—rheumatoid arthritis	0.000147	0.00273	CcSEcCtD
Metoclopramide—Hypertension—Leflunomide—rheumatoid arthritis	0.000145	0.0027	CcSEcCtD
Metoclopramide—Visual impairment—Cyclosporine—rheumatoid arthritis	0.000143	0.00267	CcSEcCtD
Metoclopramide—Anxiety—Leflunomide—rheumatoid arthritis	0.000142	0.00265	CcSEcCtD
Metoclopramide—Flushing—Cyclosporine—rheumatoid arthritis	0.000138	0.00257	CcSEcCtD
Metoclopramide—Bradycardia—Prednisolone—rheumatoid arthritis	0.000138	0.00257	CcSEcCtD
Metoclopramide—Hypotension—Azathioprine—rheumatoid arthritis	0.000136	0.00252	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—rheumatoid arthritis	0.000135	0.00252	CcSEcCtD
Metoclopramide—Bradycardia—Hydrocortisone—rheumatoid arthritis	0.000135	0.00251	CcSEcCtD
Metoclopramide—Tachycardia—Leflunomide—rheumatoid arthritis	0.000134	0.00249	CcSEcCtD
Metoclopramide—Hallucination—Hydrocortisone—rheumatoid arthritis	0.000132	0.00245	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—rheumatoid arthritis	0.000131	0.00243	CcSEcCtD
Metoclopramide—Hypotension—Leflunomide—rheumatoid arthritis	0.000128	0.00238	CcSEcCtD
Metoclopramide—Bradycardia—Triamcinolone—rheumatoid arthritis	0.000127	0.00236	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—rheumatoid arthritis	0.000127	0.00235	CcSEcCtD
Metoclopramide—Nervousness—Cyclosporine—rheumatoid arthritis	0.000126	0.00234	CcSEcCtD
Metoclopramide—Visual disturbance—Methotrexate—rheumatoid arthritis	0.000125	0.00233	CcSEcCtD
Metoclopramide—Muscle spasms—Cyclosporine—rheumatoid arthritis	0.000125	0.00232	CcSEcCtD
Metoclopramide—Insomnia—Leflunomide—rheumatoid arthritis	0.000124	0.00231	CcSEcCtD
Metoclopramide—Hallucination—Methylprednisolone—rheumatoid arthritis	0.000124	0.0023	CcSEcCtD
Metoclopramide—Dyspnoea—Leflunomide—rheumatoid arthritis	0.000122	0.00227	CcSEcCtD
Metoclopramide—Tremor—Cyclosporine—rheumatoid arthritis	0.000121	0.00226	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—rheumatoid arthritis	0.00012	0.00223	CcSEcCtD
Metoclopramide—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.00012	0.00222	CcSEcCtD
Metoclopramide—Agitation—Cyclosporine—rheumatoid arthritis	0.000119	0.00222	CcSEcCtD
Metoclopramide—Angioedema—Cyclosporine—rheumatoid arthritis	0.000118	0.0022	CcSEcCtD
Metoclopramide—Fatigue—Leflunomide—rheumatoid arthritis	0.000118	0.0022	CcSEcCtD
Metoclopramide—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000116	0.00216	CcSEcCtD
Metoclopramide—Bradycardia—Betamethasone—rheumatoid arthritis	0.000115	0.00214	CcSEcCtD
Metoclopramide—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000115	0.00214	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—rheumatoid arthritis	0.000115	0.00214	CcSEcCtD
Metoclopramide—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000115	0.00213	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—rheumatoid arthritis	0.000113	0.00211	CcSEcCtD
Metoclopramide—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.000113	0.0021	CcSEcCtD
Metoclopramide—Hallucination—Dexamethasone—rheumatoid arthritis	0.000112	0.00209	CcSEcCtD
Metoclopramide—Hallucination—Betamethasone—rheumatoid arthritis	0.000112	0.00209	CcSEcCtD
Metoclopramide—Convulsion—Cyclosporine—rheumatoid arthritis	0.000112	0.00209	CcSEcCtD
Metoclopramide—Hypertension—Cyclosporine—rheumatoid arthritis	0.000112	0.00208	CcSEcCtD
Metoclopramide—Anxiety—Cyclosporine—rheumatoid arthritis	0.00011	0.00205	CcSEcCtD
Metoclopramide—Depression—Prednisone—rheumatoid arthritis	0.000109	0.00203	CcSEcCtD
Metoclopramide—Visual impairment—Betamethasone—rheumatoid arthritis	0.000109	0.00203	CcSEcCtD
Metoclopramide—Visual impairment—Dexamethasone—rheumatoid arthritis	0.000109	0.00203	CcSEcCtD
Metoclopramide—Urticaria—Leflunomide—rheumatoid arthritis	0.000109	0.00203	CcSEcCtD
Metoclopramide—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000108	0.00202	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—rheumatoid arthritis	0.000108	0.002	CcSEcCtD
Metoclopramide—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000107	0.00199	CcSEcCtD
Metoclopramide—Confusional state—Cyclosporine—rheumatoid arthritis	0.000107	0.00198	CcSEcCtD
Metoclopramide—Oedema—Cyclosporine—rheumatoid arthritis	0.000106	0.00197	CcSEcCtD
Metoclopramide—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000105	0.00196	CcSEcCtD
Metoclopramide—Asthma—Methotrexate—rheumatoid arthritis	0.000103	0.00191	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—rheumatoid arthritis	0.000102	0.0019	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—rheumatoid arthritis	0.000102	0.00189	CcSEcCtD
Metoclopramide—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000101	0.00188	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—rheumatoid arthritis	0.0001	0.00186	CcSEcCtD
Metoclopramide—Convulsion—Hydrocortisone—rheumatoid arthritis	9.98e-05	0.00186	CcSEcCtD
Metoclopramide—Hypertension—Hydrocortisone—rheumatoid arthritis	9.94e-05	0.00185	CcSEcCtD
Metoclopramide—Diarrhoea—Azathioprine—rheumatoid arthritis	9.93e-05	0.00185	CcSEcCtD
Metoclopramide—Angioedema—Triamcinolone—rheumatoid arthritis	9.91e-05	0.00184	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—rheumatoid arthritis	9.88e-05	0.00184	CcSEcCtD
Metoclopramide—Asthenia—Leflunomide—rheumatoid arthritis	9.83e-05	0.00183	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—rheumatoid arthritis	9.79e-05	0.00182	CcSEcCtD
Metoclopramide—Anxiety—Hydrocortisone—rheumatoid arthritis	9.77e-05	0.00182	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—rheumatoid arthritis	9.62e-05	0.00179	CcSEcCtD
Metoclopramide—Neutropenia—Methotrexate—rheumatoid arthritis	9.61e-05	0.00179	CcSEcCtD
Metoclopramide—Dizziness—Azathioprine—rheumatoid arthritis	9.59e-05	0.00179	CcSEcCtD
Metoclopramide—Insomnia—Cyclosporine—rheumatoid arthritis	9.56e-05	0.00178	CcSEcCtD
Metoclopramide—Erectile dysfunction—Methotrexate—rheumatoid arthritis	9.46e-05	0.00176	CcSEcCtD
Metoclopramide—Dyspnoea—Cyclosporine—rheumatoid arthritis	9.43e-05	0.00175	CcSEcCtD
Metoclopramide—Somnolence—Cyclosporine—rheumatoid arthritis	9.4e-05	0.00175	CcSEcCtD
Metoclopramide—Oedema—Hydrocortisone—rheumatoid arthritis	9.4e-05	0.00175	CcSEcCtD
Metoclopramide—Convulsion—Triamcinolone—rheumatoid arthritis	9.39e-05	0.00175	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—rheumatoid arthritis	9.39e-05	0.00175	CcSEcCtD
Metoclopramide—Diarrhoea—Leflunomide—rheumatoid arthritis	9.37e-05	0.00174	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—rheumatoid arthritis	9.37e-05	0.00174	CcSEcCtD
Metoclopramide—Hypertension—Triamcinolone—rheumatoid arthritis	9.36e-05	0.00174	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—rheumatoid arthritis	9.34e-05	0.00174	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—rheumatoid arthritis	9.18e-05	0.00171	CcSEcCtD
Metoclopramide—Tachycardia—Hydrocortisone—rheumatoid arthritis	9.17e-05	0.00171	CcSEcCtD
Metoclopramide—Drowsiness—Methotrexate—rheumatoid arthritis	9.16e-05	0.0017	CcSEcCtD
Metoclopramide—Rash—Azathioprine—rheumatoid arthritis	9.15e-05	0.0017	CcSEcCtD
Metoclopramide—Dermatitis—Azathioprine—rheumatoid arthritis	9.14e-05	0.0017	CcSEcCtD
Metoclopramide—Depression—Methotrexate—rheumatoid arthritis	9.14e-05	0.0017	CcSEcCtD
Metoclopramide—Flushing—Prednisone—rheumatoid arthritis	9.13e-05	0.0017	CcSEcCtD
Metoclopramide—Fatigue—Cyclosporine—rheumatoid arthritis	9.12e-05	0.0017	CcSEcCtD
Metoclopramide—Headache—Azathioprine—rheumatoid arthritis	9.09e-05	0.00169	CcSEcCtD
Metoclopramide—Dizziness—Leflunomide—rheumatoid arthritis	9.06e-05	0.00169	CcSEcCtD
Metoclopramide—Angioedema—Betamethasone—rheumatoid arthritis	8.99e-05	0.00167	CcSEcCtD
Metoclopramide—Angioedema—Dexamethasone—rheumatoid arthritis	8.99e-05	0.00167	CcSEcCtD
Metoclopramide—Confusional state—Methylprednisolone—rheumatoid arthritis	8.9e-05	0.00166	CcSEcCtD
Metoclopramide—Oedema—Triamcinolone—rheumatoid arthritis	8.85e-05	0.00165	CcSEcCtD
Metoclopramide—Hypotension—Hydrocortisone—rheumatoid arthritis	8.78e-05	0.00163	CcSEcCtD
Metoclopramide—Feeling abnormal—Cyclosporine—rheumatoid arthritis	8.71e-05	0.00162	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—rheumatoid arthritis	8.7e-05	0.00162	CcSEcCtD
Metoclopramide—Rash—Leflunomide—rheumatoid arthritis	8.64e-05	0.00161	CcSEcCtD
Metoclopramide—Tachycardia—Triamcinolone—rheumatoid arthritis	8.64e-05	0.00161	CcSEcCtD
Metoclopramide—Dermatitis—Leflunomide—rheumatoid arthritis	8.63e-05	0.00161	CcSEcCtD
Metoclopramide—Nausea—Azathioprine—rheumatoid arthritis	8.62e-05	0.0016	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—rheumatoid arthritis	8.62e-05	0.0016	CcSEcCtD
Metoclopramide—Headache—Leflunomide—rheumatoid arthritis	8.58e-05	0.0016	CcSEcCtD
Metoclopramide—Agranulocytosis—Methotrexate—rheumatoid arthritis	8.55e-05	0.00159	CcSEcCtD
Metoclopramide—Convulsion—Dexamethasone—rheumatoid arthritis	8.52e-05	0.00159	CcSEcCtD
Metoclopramide—Convulsion—Betamethasone—rheumatoid arthritis	8.52e-05	0.00159	CcSEcCtD
Metoclopramide—Insomnia—Hydrocortisone—rheumatoid arthritis	8.5e-05	0.00158	CcSEcCtD
Metoclopramide—Hypertension—Dexamethasone—rheumatoid arthritis	8.49e-05	0.00158	CcSEcCtD
Metoclopramide—Hypertension—Betamethasone—rheumatoid arthritis	8.49e-05	0.00158	CcSEcCtD
Metoclopramide—Urticaria—Cyclosporine—rheumatoid arthritis	8.4e-05	0.00156	CcSEcCtD
Metoclopramide—Body temperature increased—Cyclosporine—rheumatoid arthritis	8.36e-05	0.00156	CcSEcCtD
Metoclopramide—Anxiety—Dexamethasone—rheumatoid arthritis	8.35e-05	0.00155	CcSEcCtD
Metoclopramide—Anxiety—Betamethasone—rheumatoid arthritis	8.35e-05	0.00155	CcSEcCtD
Metoclopramide—Hypotension—Methylprednisolone—rheumatoid arthritis	8.25e-05	0.00153	CcSEcCtD
Metoclopramide—Nausea—Leflunomide—rheumatoid arthritis	8.14e-05	0.00151	CcSEcCtD
Metoclopramide—Fatigue—Hydrocortisone—rheumatoid arthritis	8.1e-05	0.00151	CcSEcCtD
Metoclopramide—Oedema—Betamethasone—rheumatoid arthritis	8.03e-05	0.00149	CcSEcCtD
Metoclopramide—Oedema—Dexamethasone—rheumatoid arthritis	8.03e-05	0.00149	CcSEcCtD
Metoclopramide—Insomnia—Triamcinolone—rheumatoid arthritis	8e-05	0.00149	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—rheumatoid arthritis	7.99e-05	0.00149	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—rheumatoid arthritis	7.93e-05	0.00148	CcSEcCtD
Metoclopramide—Visual impairment—Methotrexate—rheumatoid arthritis	7.93e-05	0.00147	CcSEcCtD
Metoclopramide—Dyspnoea—Triamcinolone—rheumatoid arthritis	7.89e-05	0.00147	CcSEcCtD
Metoclopramide—Agitation—Prednisone—rheumatoid arthritis	7.87e-05	0.00146	CcSEcCtD
Metoclopramide—Tachycardia—Dexamethasone—rheumatoid arthritis	7.84e-05	0.00146	CcSEcCtD
Metoclopramide—Tachycardia—Betamethasone—rheumatoid arthritis	7.84e-05	0.00146	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—rheumatoid arthritis	7.83e-05	0.00146	CcSEcCtD
Metoclopramide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	7.79e-05	0.00145	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	7.74e-05	0.00144	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—rheumatoid arthritis	7.64e-05	0.00142	CcSEcCtD
Metoclopramide—Fatigue—Triamcinolone—rheumatoid arthritis	7.63e-05	0.00142	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—rheumatoid arthritis	7.61e-05	0.00142	CcSEcCtD
Metoclopramide—Asthenia—Cyclosporine—rheumatoid arthritis	7.59e-05	0.00141	CcSEcCtD
Metoclopramide—Hypotension—Betamethasone—rheumatoid arthritis	7.5e-05	0.0014	CcSEcCtD
Metoclopramide—Hypotension—Dexamethasone—rheumatoid arthritis	7.5e-05	0.0014	CcSEcCtD
Metoclopramide—Urticaria—Hydrocortisone—rheumatoid arthritis	7.47e-05	0.00139	CcSEcCtD
Metoclopramide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	7.43e-05	0.00138	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—rheumatoid arthritis	7.42e-05	0.00138	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—rheumatoid arthritis	7.4e-05	0.00138	CcSEcCtD
Metoclopramide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	7.29e-05	0.00136	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	7.28e-05	0.00135	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—rheumatoid arthritis	7.27e-05	0.00135	CcSEcCtD
Metoclopramide—Insomnia—Dexamethasone—rheumatoid arthritis	7.26e-05	0.00135	CcSEcCtD
Metoclopramide—Insomnia—Betamethasone—rheumatoid arthritis	7.26e-05	0.00135	CcSEcCtD
Metoclopramide—Diarrhoea—Cyclosporine—rheumatoid arthritis	7.23e-05	0.00135	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—rheumatoid arthritis	7.09e-05	0.00132	CcSEcCtD
Metoclopramide—Urticaria—Triamcinolone—rheumatoid arthritis	7.03e-05	0.00131	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—rheumatoid arthritis	7.01e-05	0.0013	CcSEcCtD
Metoclopramide—Body temperature increased—Triamcinolone—rheumatoid arthritis	7e-05	0.0013	CcSEcCtD
Metoclopramide—Dizziness—Cyclosporine—rheumatoid arthritis	6.99e-05	0.0013	CcSEcCtD
Metoclopramide—Oedema—Prednisone—rheumatoid arthritis	6.99e-05	0.0013	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	6.92e-05	0.00129	CcSEcCtD
Metoclopramide—Fatigue—Betamethasone—rheumatoid arthritis	6.92e-05	0.00129	CcSEcCtD
Metoclopramide—Fatigue—Dexamethasone—rheumatoid arthritis	6.92e-05	0.00129	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—rheumatoid arthritis	6.82e-05	0.00127	CcSEcCtD
Metoclopramide—Asthenia—Hydrocortisone—rheumatoid arthritis	6.74e-05	0.00125	CcSEcCtD
Metoclopramide—Rash—Cyclosporine—rheumatoid arthritis	6.67e-05	0.00124	CcSEcCtD
Metoclopramide—Dermatitis—Cyclosporine—rheumatoid arthritis	6.66e-05	0.00124	CcSEcCtD
Metoclopramide—Headache—Cyclosporine—rheumatoid arthritis	6.62e-05	0.00123	CcSEcCtD
Metoclopramide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	6.62e-05	0.00123	CcSEcCtD
Metoclopramide—Feeling abnormal—Betamethasone—rheumatoid arthritis	6.62e-05	0.00123	CcSEcCtD
Metoclopramide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	6.52e-05	0.00121	CcSEcCtD
Metoclopramide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	6.5e-05	0.00121	CcSEcCtD
Metoclopramide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	6.43e-05	0.0012	CcSEcCtD
Metoclopramide—Leukopenia—Methotrexate—rheumatoid arthritis	6.41e-05	0.00119	CcSEcCtD
Metoclopramide—Urticaria—Betamethasone—rheumatoid arthritis	6.38e-05	0.00119	CcSEcCtD
Metoclopramide—Urticaria—Dexamethasone—rheumatoid arthritis	6.38e-05	0.00119	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—rheumatoid arthritis	6.36e-05	0.00118	CcSEcCtD
Metoclopramide—Asthenia—Triamcinolone—rheumatoid arthritis	6.35e-05	0.00118	CcSEcCtD
Metoclopramide—Body temperature increased—Dexamethasone—rheumatoid arthritis	6.35e-05	0.00118	CcSEcCtD
Metoclopramide—Body temperature increased—Betamethasone—rheumatoid arthritis	6.35e-05	0.00118	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—rheumatoid arthritis	6.33e-05	0.00118	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—rheumatoid arthritis	6.32e-05	0.00118	CcSEcCtD
Metoclopramide—Nausea—Cyclosporine—rheumatoid arthritis	6.28e-05	0.00117	CcSEcCtD
Metoclopramide—Dizziness—Hydrocortisone—rheumatoid arthritis	6.21e-05	0.00116	CcSEcCtD
Metoclopramide—Convulsion—Methotrexate—rheumatoid arthritis	6.2e-05	0.00115	CcSEcCtD
Metoclopramide—Rash—Prednisolone—rheumatoid arthritis	6.07e-05	0.00113	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—rheumatoid arthritis	6.06e-05	0.00113	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	6.04e-05	0.00112	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—rheumatoid arthritis	6.03e-05	0.00112	CcSEcCtD
Metoclopramide—Headache—Prednisolone—rheumatoid arthritis	6.03e-05	0.00112	CcSEcCtD
Metoclopramide—Rash—Hydrocortisone—rheumatoid arthritis	5.93e-05	0.0011	CcSEcCtD
Metoclopramide—Dermatitis—Hydrocortisone—rheumatoid arthritis	5.92e-05	0.0011	CcSEcCtD
Metoclopramide—Confusional state—Methotrexate—rheumatoid arthritis	5.89e-05	0.0011	CcSEcCtD
Metoclopramide—Headache—Hydrocortisone—rheumatoid arthritis	5.89e-05	0.0011	CcSEcCtD
Metoclopramide—Dizziness—Triamcinolone—rheumatoid arthritis	5.85e-05	0.00109	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—rheumatoid arthritis	5.84e-05	0.00109	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—rheumatoid arthritis	5.76e-05	0.00107	CcSEcCtD
Metoclopramide—Asthenia—Dexamethasone—rheumatoid arthritis	5.76e-05	0.00107	CcSEcCtD
Metoclopramide—Asthenia—Betamethasone—rheumatoid arthritis	5.76e-05	0.00107	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—rheumatoid arthritis	5.72e-05	0.00106	CcSEcCtD
Metoclopramide—Nausea—Hydrocortisone—rheumatoid arthritis	5.58e-05	0.00104	CcSEcCtD
Metoclopramide—Rash—Triamcinolone—rheumatoid arthritis	5.58e-05	0.00104	CcSEcCtD
Metoclopramide—Dermatitis—Triamcinolone—rheumatoid arthritis	5.57e-05	0.00104	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—rheumatoid arthritis	5.57e-05	0.00104	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—rheumatoid arthritis	5.56e-05	0.00103	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—rheumatoid arthritis	5.55e-05	0.00103	CcSEcCtD
Metoclopramide—Headache—Triamcinolone—rheumatoid arthritis	5.54e-05	0.00103	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—rheumatoid arthritis	5.53e-05	0.00103	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—rheumatoid arthritis	5.53e-05	0.00103	CcSEcCtD
Metoclopramide—Diarrhoea—Dexamethasone—rheumatoid arthritis	5.49e-05	0.00102	CcSEcCtD
Metoclopramide—Diarrhoea—Betamethasone—rheumatoid arthritis	5.49e-05	0.00102	CcSEcCtD
Metoclopramide—Hypotension—Methotrexate—rheumatoid arthritis	5.46e-05	0.00102	CcSEcCtD
Metoclopramide—Dizziness—Dexamethasone—rheumatoid arthritis	5.31e-05	0.000988	CcSEcCtD
Metoclopramide—Dizziness—Betamethasone—rheumatoid arthritis	5.31e-05	0.000988	CcSEcCtD
Metoclopramide—Insomnia—Methotrexate—rheumatoid arthritis	5.29e-05	0.000983	CcSEcCtD
Metoclopramide—Nausea—Triamcinolone—rheumatoid arthritis	5.26e-05	0.000978	CcSEcCtD
Metoclopramide—Nausea—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.000976	CcSEcCtD
Metoclopramide—Dyspnoea—Methotrexate—rheumatoid arthritis	5.21e-05	0.000969	CcSEcCtD
Metoclopramide—Somnolence—Methotrexate—rheumatoid arthritis	5.19e-05	0.000967	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—rheumatoid arthritis	5.15e-05	0.000958	CcSEcCtD
Metoclopramide—Rash—Betamethasone—rheumatoid arthritis	5.06e-05	0.000942	CcSEcCtD
Metoclopramide—Rash—Dexamethasone—rheumatoid arthritis	5.06e-05	0.000942	CcSEcCtD
Metoclopramide—Dermatitis—Betamethasone—rheumatoid arthritis	5.06e-05	0.000941	CcSEcCtD
Metoclopramide—Dermatitis—Dexamethasone—rheumatoid arthritis	5.06e-05	0.000941	CcSEcCtD
Metoclopramide—Fatigue—Methotrexate—rheumatoid arthritis	5.04e-05	0.000937	CcSEcCtD
Metoclopramide—Headache—Dexamethasone—rheumatoid arthritis	5.03e-05	0.000936	CcSEcCtD
Metoclopramide—Headache—Betamethasone—rheumatoid arthritis	5.03e-05	0.000936	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—rheumatoid arthritis	5.02e-05	0.000933	CcSEcCtD
Metoclopramide—Feeling abnormal—Methotrexate—rheumatoid arthritis	4.82e-05	0.000896	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—rheumatoid arthritis	4.78e-05	0.00089	CcSEcCtD
Metoclopramide—Nausea—Dexamethasone—rheumatoid arthritis	4.77e-05	0.000887	CcSEcCtD
Metoclopramide—Nausea—Betamethasone—rheumatoid arthritis	4.77e-05	0.000887	CcSEcCtD
Metoclopramide—Urticaria—Methotrexate—rheumatoid arthritis	4.64e-05	0.000864	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—rheumatoid arthritis	4.62e-05	0.00086	CcSEcCtD
Metoclopramide—Body temperature increased—Methotrexate—rheumatoid arthritis	4.62e-05	0.000859	CcSEcCtD
Metoclopramide—Rash—Prednisone—rheumatoid arthritis	4.41e-05	0.00082	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—rheumatoid arthritis	4.4e-05	0.000819	CcSEcCtD
Metoclopramide—Headache—Prednisone—rheumatoid arthritis	4.38e-05	0.000815	CcSEcCtD
Metoclopramide—Hypersensitivity—Methotrexate—rheumatoid arthritis	4.31e-05	0.000801	CcSEcCtD
Metoclopramide—Asthenia—Methotrexate—rheumatoid arthritis	4.19e-05	0.00078	CcSEcCtD
Metoclopramide—Nausea—Prednisone—rheumatoid arthritis	4.15e-05	0.000773	CcSEcCtD
Metoclopramide—Diarrhoea—Methotrexate—rheumatoid arthritis	4e-05	0.000744	CcSEcCtD
Metoclopramide—Dizziness—Methotrexate—rheumatoid arthritis	3.86e-05	0.000719	CcSEcCtD
Metoclopramide—Rash—Methotrexate—rheumatoid arthritis	3.68e-05	0.000686	CcSEcCtD
Metoclopramide—Dermatitis—Methotrexate—rheumatoid arthritis	3.68e-05	0.000685	CcSEcCtD
Metoclopramide—Headache—Methotrexate—rheumatoid arthritis	3.66e-05	0.000681	CcSEcCtD
Metoclopramide—Nausea—Methotrexate—rheumatoid arthritis	3.47e-05	0.000646	CcSEcCtD
Metoclopramide—DRD2—Signaling by GPCR—RASGRP1—rheumatoid arthritis	1e-05	0.000285	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—rheumatoid arthritis	9.99e-06	0.000283	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALB—rheumatoid arthritis	9.94e-06	0.000282	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	9.94e-06	0.000282	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	9.83e-06	0.000279	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PRKCQ—rheumatoid arthritis	9.83e-06	0.000279	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL3—rheumatoid arthritis	9.78e-06	0.000277	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL2—rheumatoid arthritis	9.78e-06	0.000277	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—rheumatoid arthritis	9.77e-06	0.000277	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	9.66e-06	0.000274	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GC—rheumatoid arthritis	9.66e-06	0.000274	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR5—rheumatoid arthritis	9.65e-06	0.000274	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	9.62e-06	0.000273	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SAA1—rheumatoid arthritis	9.56e-06	0.000271	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL10—rheumatoid arthritis	9.52e-06	0.00027	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—NOS3—rheumatoid arthritis	9.51e-06	0.00027	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2RA—rheumatoid arthritis	9.51e-06	0.00027	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IRAK1—rheumatoid arthritis	9.45e-06	0.000268	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TLE3—rheumatoid arthritis	9.45e-06	0.000268	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL8—rheumatoid arthritis	9.43e-06	0.000268	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—C3—rheumatoid arthritis	9.43e-06	0.000267	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—POMC—rheumatoid arthritis	9.4e-06	0.000267	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NCF1—rheumatoid arthritis	9.36e-06	0.000266	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.36e-06	0.000265	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL10—rheumatoid arthritis	9.31e-06	0.000264	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TLE3—rheumatoid arthritis	9.25e-06	0.000262	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IRAK1—rheumatoid arthritis	9.25e-06	0.000262	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.16e-06	0.00026	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—rheumatoid arthritis	9.14e-06	0.000259	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCL5—rheumatoid arthritis	9.02e-06	0.000256	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—rheumatoid arthritis	9.01e-06	0.000256	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2RB—rheumatoid arthritis	9.01e-06	0.000256	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CD28—rheumatoid arthritis	9e-06	0.000255	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	8.98e-06	0.000255	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—rheumatoid arthritis	8.97e-06	0.000254	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—rheumatoid arthritis	8.95e-06	0.000254	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CSF2—rheumatoid arthritis	8.89e-06	0.000252	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCL5—rheumatoid arthritis	8.83e-06	0.00025	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2RB—rheumatoid arthritis	8.82e-06	0.00025	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—rheumatoid arthritis	8.79e-06	0.000249	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C5—rheumatoid arthritis	8.7e-06	0.000247	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—rheumatoid arthritis	8.7e-06	0.000247	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CSF2—rheumatoid arthritis	8.7e-06	0.000247	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL8—rheumatoid arthritis	8.69e-06	0.000247	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—MMP3—rheumatoid arthritis	8.68e-06	0.000246	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—rheumatoid arthritis	8.57e-06	0.000243	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NFATC1—rheumatoid arthritis	8.56e-06	0.000243	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—rheumatoid arthritis	8.53e-06	0.000242	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C5—rheumatoid arthritis	8.51e-06	0.000242	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL8—rheumatoid arthritis	8.51e-06	0.000241	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—MMP3—rheumatoid arthritis	8.49e-06	0.000241	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.48e-06	0.00024	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	8.48e-06	0.00024	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NFKB1—rheumatoid arthritis	8.44e-06	0.000239	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NFATC1—rheumatoid arthritis	8.38e-06	0.000238	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BDKRB2—rheumatoid arthritis	8.31e-06	0.000236	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL12—rheumatoid arthritis	8.31e-06	0.000236	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—rheumatoid arthritis	8.3e-06	0.000235	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAPK8—rheumatoid arthritis	8.3e-06	0.000235	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6ST—rheumatoid arthritis	8.24e-06	0.000234	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.22e-06	0.000233	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NOS3—rheumatoid arthritis	8.2e-06	0.000233	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL5—rheumatoid arthritis	8.19e-06	0.000232	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR6—rheumatoid arthritis	8.18e-06	0.000232	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR5—rheumatoid arthritis	8.13e-06	0.000231	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CSF2—rheumatoid arthritis	8.07e-06	0.000229	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL5—rheumatoid arthritis	8.02e-06	0.000227	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—rheumatoid arthritis	8.01e-06	0.000227	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	8.01e-06	0.000227	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR6—rheumatoid arthritis	8.01e-06	0.000227	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NCF2—rheumatoid arthritis	7.96e-06	0.000226	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR5—rheumatoid arthritis	7.95e-06	0.000226	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—C3—rheumatoid arthritis	7.94e-06	0.000225	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CSF2—rheumatoid arthritis	7.9e-06	0.000224	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MED1—rheumatoid arthritis	7.88e-06	0.000224	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	7.84e-06	0.000222	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NCF2—rheumatoid arthritis	7.79e-06	0.000221	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—C3—rheumatoid arthritis	7.77e-06	0.000221	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SH2B3—rheumatoid arthritis	7.75e-06	0.00022	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TRAF6—rheumatoid arthritis	7.75e-06	0.00022	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.75e-06	0.00022	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SYK—rheumatoid arthritis	7.73e-06	0.000219	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GZMB—rheumatoid arthritis	7.71e-06	0.000219	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NOS3—rheumatoid arthritis	7.67e-06	0.000217	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—rheumatoid arthritis	7.66e-06	0.000217	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SH2B3—rheumatoid arthritis	7.59e-06	0.000215	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TRAF6—rheumatoid arthritis	7.59e-06	0.000215	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.59e-06	0.000215	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GZMB—rheumatoid arthritis	7.54e-06	0.000214	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—rheumatoid arthritis	7.54e-06	0.000214	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—rheumatoid arthritis	7.5e-06	0.000213	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL3—rheumatoid arthritis	7.48e-06	0.000212	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL2—rheumatoid arthritis	7.48e-06	0.000212	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT1—rheumatoid arthritis	7.45e-06	0.000211	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR5—rheumatoid arthritis	7.38e-06	0.000209	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL2—rheumatoid arthritis	7.38e-06	0.000209	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6R—rheumatoid arthritis	7.35e-06	0.000209	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL10—rheumatoid arthritis	7.35e-06	0.000208	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	7.32e-06	0.000208	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	7.32e-06	0.000208	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	7.32e-06	0.000208	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL3—rheumatoid arthritis	7.32e-06	0.000208	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SAA1—rheumatoid arthritis	7.32e-06	0.000208	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.27e-06	0.000206	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	7.22e-06	0.000205	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—C3—rheumatoid arthritis	7.21e-06	0.000205	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NCF1—rheumatoid arthritis	7.16e-06	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SAA1—rheumatoid arthritis	7.16e-06	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.12e-06	0.000202	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—C3—rheumatoid arthritis	7.06e-06	0.0002	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—rheumatoid arthritis	7.03e-06	0.000199	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NCF1—rheumatoid arthritis	7.01e-06	0.000199	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—rheumatoid arthritis	7.01e-06	0.000199	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CD28—rheumatoid arthritis	6.89e-06	0.000195	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CD28—rheumatoid arthritis	6.74e-06	0.000191	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP3—rheumatoid arthritis	6.7e-06	0.00019	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TYK2—rheumatoid arthritis	6.7e-06	0.00019	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BGN—rheumatoid arthritis	6.59e-06	0.000187	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.49e-06	0.000184	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTK2—rheumatoid arthritis	6.45e-06	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.42e-06	0.000182	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL12—rheumatoid arthritis	6.36e-06	0.00018	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.36e-06	0.00018	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—rheumatoid arthritis	6.35e-06	0.00018	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.35e-06	0.00018	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL5—rheumatoid arthritis	6.32e-06	0.000179	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.31e-06	0.000179	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.29e-06	0.000178	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CSF2—rheumatoid arthritis	6.23e-06	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	6.23e-06	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.23e-06	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	6.22e-06	0.000176	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.17e-06	0.000175	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.16e-06	0.000175	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—rheumatoid arthritis	6.14e-06	0.000174	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	6.07e-06	0.000172	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.93e-06	0.000168	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SYK—rheumatoid arthritis	5.91e-06	0.000168	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SPP1—rheumatoid arthritis	5.86e-06	0.000166	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.83e-06	0.000165	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.81e-06	0.000165	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.8e-06	0.000165	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—rheumatoid arthritis	5.79e-06	0.000164	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SYK—rheumatoid arthritis	5.79e-06	0.000164	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—rheumatoid arthritis	5.77e-06	0.000164	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT1—rheumatoid arthritis	5.7e-06	0.000162	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR5—rheumatoid arthritis	5.7e-06	0.000162	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.68e-06	0.000161	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—rheumatoid arthritis	5.65e-06	0.00016	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—rheumatoid arthritis	5.64e-06	0.00016	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6R—rheumatoid arthritis	5.63e-06	0.00016	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL10—rheumatoid arthritis	5.62e-06	0.000159	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2RA—rheumatoid arthritis	5.62e-06	0.000159	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT1—rheumatoid arthritis	5.58e-06	0.000158	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—rheumatoid arthritis	5.57e-06	0.000158	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—C3—rheumatoid arthritis	5.57e-06	0.000158	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	5.52e-06	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	5.51e-06	0.000156	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.5e-06	0.000156	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—rheumatoid arthritis	5.3e-06	0.00015	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LEP—rheumatoid arthritis	5.18e-06	0.000147	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP3—rheumatoid arthritis	5.13e-06	0.000145	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TYK2—rheumatoid arthritis	5.12e-06	0.000145	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP3—rheumatoid arthritis	5.02e-06	0.000142	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	5.02e-06	0.000142	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	4.95e-06	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTK2—rheumatoid arthritis	4.94e-06	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.91e-06	0.000139	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FN1—rheumatoid arthritis	4.89e-06	0.000139	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6ST—rheumatoid arthritis	4.87e-06	0.000138	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL5—rheumatoid arthritis	4.84e-06	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTK2—rheumatoid arthritis	4.83e-06	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.81e-06	0.000136	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CSF2—rheumatoid arthritis	4.77e-06	0.000135	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	4.74e-06	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—rheumatoid arthritis	4.7e-06	0.000133	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CD80—rheumatoid arthritis	4.69e-06	0.000133	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	4.67e-06	0.000132	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	4.6e-06	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	4.48e-06	0.000127	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.46e-06	0.000127	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—rheumatoid arthritis	4.45e-06	0.000126	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	4.39e-06	0.000124	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.37e-06	0.000124	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	4.36e-06	0.000124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—rheumatoid arthritis	4.36e-06	0.000124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6R—rheumatoid arthritis	4.34e-06	0.000123	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	4.3e-06	0.000122	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	4.27e-06	0.000121	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	4.26e-06	0.000121	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C3—rheumatoid arthritis	4.26e-06	0.000121	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.21e-06	0.000119	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	4.17e-06	0.000118	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	4.17e-06	0.000118	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	3.97e-06	0.000113	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	3.96e-06	0.000112	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	3.88e-06	0.00011	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	3.88e-06	0.00011	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	3.74e-06	0.000106	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	3.73e-06	0.000106	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	3.66e-06	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.65e-06	0.000103	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	3.59e-06	0.000102	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAT—rheumatoid arthritis	3.56e-06	0.000101	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	3.51e-06	9.96e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	3.44e-06	9.77e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	3.41e-06	9.67e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	3.33e-06	9.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	3.33e-06	9.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	3.32e-06	9.43e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	3.29e-06	9.34e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	3.28e-06	9.29e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	3.26e-06	9.26e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	3.25e-06	9.23e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	3.12e-06	8.84e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	3.08e-06	8.75e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	3.03e-06	8.6e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	3.03e-06	8.59e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	2.97e-06	8.43e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	2.97e-06	8.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	2.96e-06	8.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	2.91e-06	8.25e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.8e-06	7.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	2.64e-06	7.48e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.58e-06	7.32e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.57e-06	7.29e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	2.52e-06	7.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	2.51e-06	7.11e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	2.47e-06	6.99e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	2.45e-06	6.96e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	2.38e-06	6.76e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—rheumatoid arthritis	2.38e-06	6.74e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	2.36e-06	6.69e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	2.33e-06	6.62e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	2.32e-06	6.58e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.31e-06	6.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.27e-06	6.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—rheumatoid arthritis	2.17e-06	6.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.14e-06	6.07e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	2.11e-06	6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.1e-06	5.94e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	2.07e-06	5.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.96e-06	5.57e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	1.94e-06	5.49e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.92e-06	5.46e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.9e-06	5.38e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	1.62e-06	4.59e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	1.58e-06	4.49e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	1.48e-06	4.2e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	1.45e-06	4.11e-05	CbGpPWpGaD
